Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SARS and Avian Flu -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (966)	8/31/2003 9:40:25 AM
From: chomolungma	Read Replies (1) \| Respond to of 4232

Henry, Thanks for the information you provide this thread and the time you spend posting here. I have a question about your comments" The SARS CoVs are easily transmitted by patients with "summer cold" symptoms. Seasonal cofactors may be required for the SARS presentation seen last winter and spring. So what you are saying is that the SARS CoV is being spread unbeknownst to us during this summer season, and when winter arrives it will resurface in its deadly form? Correct? Are there other examples of viruses that do this, i.e. spread in a mild form and then turn deadly later? Do any other coronaviruses exhibit this behaviour? What are the cofactors that cause this change from mild to deadly? I am not a scientist, only an investor trying to weigh the risks of a SARS outbreak this winter and the information that has been posted on this forum about seasonality seems to suggest that most viruses "disappear" during their "offseasons" not that they change their potencies. What am I missing? Thanks.